Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Licenses SNP-IT Tech to Estonian Start Up

NEW YORK, Jan. 24 - Estonian genotyping company Asper Biotech will use Orchid BioSciences' SNP-IT technology in a new slide-based array product aimed at bioscience research, the companies said on Thursday.


Under the deal, which is arranged as a non-exclusive license, Orchid will receive an upfront payment and royalties on sales. The companies did not disclose details.


SNP-IT is Orchid's primer extension SNP scoring technology. Asper's system, called Genorama, is a four-color SNP scoring device for medium-throughput genotyping.


Asper Biotech is a privately held biotech firm founded in 1999 in Tartu, Estonia. Last summer it launched a p53 gene-sequencing and mutation-detection bioarray chip. It is also involved with the Estonian government and Gene Bank project in efforts to establish a population genetics database.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.